Psiquiatría y Neurología

The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs

Genome-scale study of Huntingtons disease identifies potential drug targets

Personalized pharmacotherapy in psychiatry

Psychiatric PGx predicts health resource utilization of

PharmaGKB summary - phenytoin pathway

Risk factors associated with metabolic syndrome in bipolar and schizophrenia

The pharmacogenetics of sympton response to antipsychotic drugs

Genomics of dementia- APOE and CYP2D6-related pharmacogenetics

Pharmacogenomics and personalized medicine in neuropsychiatry

Pharmacogenetics of antidepressive drugs

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR-D

A meta-analysis of the VAl158Met COMT polymorphism and violent behavior in schizophrenia

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE stydy

Using a pharmacogenomic algorithm to guide the treatment of depression

Pharmacogenetics of antipsychotics-recent progress and methodological issues

Importance of pharmacogenetics in the treatment of children with ADHD

Regresar al Acervo